William Blair & Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.23M | Sell |
|
|||||
|
2025
Q1 | $11.2M | Sell |
|
|||||
|
2024
Q4 | $12.6M | Sell |
|
|||||
|
2024
Q3 | $14.2M | Buy |
|
|||||
|
2024
Q2 | $13.1M | Sell |
|
|||||
|
2024
Q1 | $14.3M | Buy |
|
|||||
|
2023
Q4 | $9.42M | Sell |
|
|||||
|
2023
Q3 | $7.86M | Sell |
|
|||||
|
2023
Q2 | $9.08M | Buy |
|
|||||
|
2023
Q1 | $8.16M | Sell |
|
|||||
|
2022
Q4 | $8.92M | Buy |
|
|||||
|
2022
Q3 | $8.17M | Buy |
|
|||||
|
2022
Q2 | $5.32M | Buy |
|
|||||
|
2022
Q1 | $5.09M | Sell |
|
|||||
|
2021
Q4 | $8.78M | Sell |
|
|||||
|
2021
Q3 | $11.5M | Buy |
|
|||||
|
2021
Q2 | $11.7M | Sell |
|
|||||
|
2021
Q1 | $12.8M | Sell |
|
|||||
|
2020
Q4 | $35.4M | Buy |
|
|||||
|
2020
Q3 | $5.92M | Buy |
|
|||||
|
2020
Q2 | $2.59M | Buy |
|
|||||
|
2020
Q1 | $842K | Sell |
|
|||||
|
2019
Q4 | $1.1M | Sell |
|
|||||
|
2019
Q3 | $1.14M | Sell |
|
|||||
|
2019
Q2 | $1.55M | Sell |
|
|||||
|
2019
Q1 | $3.13M | Buy |
|
|||||
|
2018
Q4 | $614K | Buy |
|
|||||
|
2018
Q3 | $459K | Buy |
|
|||||
|
2018
Q2 | $418K | Buy |
|
|||||
|
2018
Q1 | $279K | Buy |
|
|||||
|
2017
Q4 | $236K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $227K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $385K | Buy |
|